TFA
OPNT

Tobias Financial Advisors’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Tobias Financial Advisors’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,724
Closed -$39K – 309
2019
Q4 		$39K Buy
+2,724
New +$39.7K 0.03% 105

Other funds holding OPNT

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Tobias Financial Advisors's OPNT Position: Q1 2020 in Review

Tobias Financial Advisors sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2020, closing a stake of 2,724 shares — an estimated $39K sold.

Tobias Financial Advisors first reported a position in OPNT in Q4 2019 and held it in 1 quarter. The position peaked at $39K in Q4 2019. 31 funds tracked by Wall St. Rank hold OPNT as of Q1 2020.

  • Tobias Financial Advisors reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Tobias Financial Advisors sold 2,724 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $39K.
  • Tobias Financial Advisors first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Tobias Financial Advisors's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $39K in Q4 2019.
  • 31 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Tobias Financial Advisors's 13F filing for Q1 2020, filed 13 May 2020.